“Data is our currency” – with Ginkgo Datapoints’ John Androsavich

Successful use of AI is becoming a key differentiator for pharma companies. And one of the most important ways to maximise the value from AI is to have high-quality training data.

At Reuters Pharma USA last month, editor-in-chief Jonah Comstock caught up with John Androsavich, general manager of Ginkgo Datapoints, an AI-driven CRO launched by Ginkgo Bioworks last September.

In the video below, Androsavich explains how Ginkgo Datapoints generates data and provides it as a service to pharma companies, biotechs, and more – and why data, not models or architecture, is the biggest bottleneck in pharma AI.

They discuss the success of Google’s AlphaFold and why it’s been hard to replicate in other areas, what sorts of companies are interested in this data and why, and how to succeed in a crowded AI market.

At the end of the video, Androsavich also delves into future trends in AI: combining AI with research in the real world via “lab in the loop” protocols. Check out the full video for a fascinating conversation about the power of good data in pharmaceutical research.